HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study on the diagnosis of rabbit VX2 esophageal cancer and stent-therapy efficacy based on multiphoton microscopy.

Abstract
Histopathology is the gold standard for diagnosis of esophageal carcinoma. Based on two photon excited fluorescence (TPEF) and second harmonic generation (SHG), multiphoton microscopy (MPM) has become a novel optical tool adjunct to current histopathological techniques without any exogenous contrast agents. We thus investigated the potential of using TPEF and SHG techniques for differentiating cancer tissues from cancer tissues after paclitaxel-eluting stent implantation and normal esophageal tissues which are fresh and unstained without dying from the VX2 esophageal carcinoma rabbit models. Comparisons were made between MPM imaging and gold standard sections for each specimen stained with hematoxylin-eosin (H&E). Our results indicated that the MPM imaging technique could identify and distinguish among normal esophageal tissues, cancer tissues, as well as cancer tissues after stent implantation. Therefore, MPM potentially offers a powerful tool to not only diagnose esophageal cancer but also monitor stent-therapy efficacy.
AuthorsLimei Ma, Xiaoyang Huang, Xiaohong Wang, Yong Zhang, Li Liu, Yu Sheng, Zhining Fan
JournalScanning (Scanning) 2015 Mar-Apr Vol. 37 Issue 2 Pg. 152-7 ISSN: 1932-8745 [Electronic] England
PMID25675898 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© Wiley Periodicals, Inc.
Chemical References
  • Antineoplastic Agents
  • Paclitaxel
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma (diagnosis, drug therapy, pathology, surgery)
  • Disease Models, Animal
  • Drug-Eluting Stents
  • Esophageal Neoplasms (diagnosis, drug therapy, pathology, surgery)
  • Image Processing, Computer-Assisted (methods)
  • Microscopy, Fluorescence, Multiphoton (methods)
  • Paclitaxel (therapeutic use)
  • Rabbits
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: